News
WASHINGTON — The House passed President Trump’s tax-cutting plan early Thursday morning with the attendant health care ...
A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...
STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...
The MAHA commission's assessment of children's health mirrored RFK Jr.'s familiar targets. The question now is what remedies ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...
Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...
As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.
His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...
The House Rules Committee passed the budget reconciliation bill late Wednesday night, teeing it up for House floor action.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results